REFERENCES
1. Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006;42:2212-21.
2. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18.
3. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010;76:S94-100.
5. Palma DA, Olson R, Harrow S, Gaede S, Louie AV, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 2019;393:2051-8.
6. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, et al. American society for therapeutic radiology and oncology (ASTRO) and American college of radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010;76:326-32.
7. Scorsetti M, Comito T, Tozzi A, Navarria P, Fogliata A, et al. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol 2015;14:543-53.
8. Goodman BD, Mannina EM, Althouse SK, Maluccio MA, Cárdenes HR. Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases. Pract Radiat Oncol 2016;6:86-95.
9. McPartlin A, Swaminath A, Wang R, Pintilie M, Brierley J, et al. Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases. Int J Radiat Oncol Biol Phys 2017;99:388-95.
10. Joo JH, Park JH, Kim JC, Yu CS, Lim SB, et al. Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer. Int J Radiat Oncol Biol Phys 2017;99:876-83.
11. Mahadevan A, Blanck O, Lanciano R, Peddada A, Sundararaman S, et al. Stereotactic body radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch(R) patient registry. Radiat Oncol 2018;13:26.
12. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965;93:200-8.
13. Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45:823-30.
14. Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 2004;5:550-60.
15. Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009;45:1748-56.
16. Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR. Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases. Int J Radiat Oncol Biol Phys 2018;100:950-8.
17. Dritschilo A, Grant EG, Harter KW, Holt RW, Rustgi SN, et al. Interstitial radiation therapy for hepatic metastases: sonographic guidance for applicator placement. AJR Am J Roentgenol 1986;147:275-8.
18. Thomas DS, Nauta RJ, Rodgers JE, Popescu GF, Nguyen H, et al. Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 1993;71:1977-81.
19. Ricke J, Wust P, Wieners G, Beck A, Cho CH, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004;15:1279-86.
20. Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010;78:479-85.
21. Mohnike K, Wolf S, Damm R, Seidensticker M, Seidensticker R, et al. Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy: complications and risk factors. Strahlenther Onkol 2016;192:288-96.
22. Tselis N, Chatzikonstantinou G, Kolotas C, Milickovic N, Baltas D, et al. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol 2013;23:2264-70.
23. Collettini F, Singh A, Schnapauff D, Powerski MJ, Denecke T, et al. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol 2013;82:e509-14.
24. Wieners G, Mohnike K, Peters N, Bischoff J, Kleine-Tebbe A, et al. Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study. Radiother Oncol 2011;100:314-9.
25. Collettini F, Golenia M, Schnapauff D, Poellinger A, Denecke T, et al. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. J Vasc Interv Radiol 2012;23:618-26.
26. Sharma DN, Thulkar S, Sharma S, Gandhi AK, Haresh KP, et al. High-dose-rate interstitial brachytherapy for liver metastases: first study from India. J Contemp Brachytherapy 2013;5:70-5.
27. Kieszko D, Cisek P, Kordzińska-Cisek I, Grzybowska-Szatkowska L. Treatment of hepatic metastases with computed tomography-guided interstitial brachytherapy. Oncol Lett 2018;15:8717-22.
28. Omari J, Heinze C, Damm R, Hass P, Janitzky A, et al. Radioablation of hepatic metastases from renal cell carcinoma with image-guided interstitial brachytherapy. Anticancer Res 2019;39:2501-8.
29. Hass P, Mohnike K, Kropf S, Brunner TB, Walke M, et al. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies. Brachytherapy 2019;18:823-8.
30. Yeo SG, Kim DY, Kim TH, Kim SY, Hong YS, et al. Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction. Radiat Oncol 2010;5:97.
31. Cunningham SC, Choti MA, Bellavance EC, Pawlik TM. Palliation of hepatic tumors. Surg Oncol 2007;16:277-91.
32. Greco C, Catalano G, Di Grazia A, Orecchia R. Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy. Tumori 2004;90:73-9.
33. Bydder S, Spry NA, Christie DR, Roos D, Burmeister BH, et al. A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol 2003;47:284-8.
34. Edyta WR, Jakub L, Jerzy W. Whole liver palliative radiotherapy for patients with massive liver metastases. Asian Pac J Cancer Prev 2015;16:6381-4.
35. Yin H, Lu K, Qiao WB, Zhang HY, Sun D, et al. Whole-liver radiotherapy concurrent with chemotherapy as a palliative treatment for colorectal patients with massive and multiple liver metastases: a retrospective study. Asian Pac J Cancer Prev 2014;15:1597-602.
